Some particularities of quality of life in patients with chronic hepatopathies
DOI:
https://doi.org/10.52692/1857-0011.2025.2-82.09Keywords:
Quality of life, the SF-36 questionnaire, chronic HBV infection, associated metabolic fatty liver diseaseAbstract
Quality of life (QoL) in medicine means the physical, mental and social well-being, as well as the patients’ ability to perform the usual tasks in their daily existence. Chronic hepatopathies are accompanied by a variety of somatic, psychological and social problems, which affect the patient’s QoL.The aim of the study: to study quality of life indices in patients with chronic hepatopathies in the Republic of Moldova. There were 59 patients with various chronic hepatopathies: 34 patients with chronic hepatitis B virus infection (CHVI-HBV group), 25 patients with steatotic liver disease associated with metabolic dysfunctions (SLDAMD group) and 26 apparently healthy individuals (control group). The SF-36 questionnaire was used to assess QoL. The lowest levels of QoL integral parameters were appreciated in the CHVI-HBV group: Physical Health Index (PH) - 46.69±1.22, Mental Health Index (MH) - 38.97±1.56 points. In the SLDAMD group PH were 47.02±1.37 and MH - 45.91±1.55 points. In the control group, the average values of PH - 53.01±0.91 and MH - 51.51±1.50 (р<0.01 with both study groups). The analysis of the results after the scores parameters reflects the maintenance of diminishing values trend in the CHVI-HBV group. PH scores of QoL demonstrate a weaker decrease. The SF-36 questionnaire can be used in patients with liver pathology; in chronic hepatopathies most QoL indicators decrease, with more severe damage in the mental component; in most patients with chronic hepatopathies the quality of life is affected, being more pronounced in liver diseases of viral origin.
References
Фурдуй Ф.И., Чокинэ В.К., Фурдуй В.Ф., Глижин А.Г., Врабие В.Г., Шептицкий В.А. Трактат о Научных и Практических Основах Санокреатологии. Том II. Психическое Здоровье. Психосанокреатология. Необходимость Общества в Ее Развитии. Ed a 2-a. Chișinău: Tipografia ASM, 2018; 360 p. ISBN 978-9975- 62-399-5.
Lupu I. Calitatea vieţii în sănătate. Definiţii şi instrumente de evaluare. Calitatea Vieții (Quality of Life). 2006; 17(1-2):73-91. E-ISSN: 1844-5292. https://www.revistacalitateavietii.ro/journal/article/view/649.
Gorobievschi S. Conceptul calității vieții la interconexiunea cu sănătatea publică. Implicațiile economice și sociale ale pandemiei COVID-19: analize, prognoze și strategii de atenuare a consecințelor: Mater. Conf. Şt. Intern. 23 octombrie 2020. Chişinău, 2020; 2020:197-199. ISBN 978-9975-3463-3-7. https://ibn.idsi.md/sites/default/files/imag_file/197-199_4.pdf.
Березовская, Е. Изменения показателей качества жизни пациентов c хроническими гепатопатиями. Український вісник медико-соціальної експертизи, 2019; 3-4 (33-34):20-24. ISSN 2224-0454. https://ibn.idsi.md/ro/vizualizare_articol/201342.
WHO. Global Health Sector Strategy on Viral Hepatitis 2016-2021. The WHO Document Production Services, Geneva, Switzerland, 2016; 56 p. https://iris.who.int/bitstream/handle/10665/246177/WHO-HIV-2016.06-eng.pdf.
WHO. Liver disease death rate by country. https://www.worldlifeexpectancy.com/cause-of-death/liver-disease/by-country/.
Dumbrava, V.-T., Lupașco, Iu., Venger, I., Berzovscaia, E. Ficatul și hormonii: de la mecanismele esențiale până la manifes tările clinice și extrahepatice. (Monografie). Chisinau: „Print-Caro”, 2016; 203 p. ISBN 978-9975-56-404-5.
Prisacari V., ParaschivA., Spînu C., și al. Hepatitele virale parenterale și ciroze hepatice – epidemiologia, clinica, diagnosticul, tratamentul, prevenirea și controlul. Ghid. Chisinau, 2013; 160p.
Lupaşco Iu. Hepatitele cronice şi alte forme ale bolilor cronice difuze ale ficatului (screening-ul profilactic, frecvenţa, factorii de risc, diagnosticul clinico-paraclinic şi statutul hormonal, tratamentul). Monografie. Chişinău: Ericon, 2014; 328 p. ISBN 978-9975-3018-2-4.
Younossi ZM, Stepanova M, Esteban R, et al. Superiority of interferon-free regimens for chronic hepatitis C: The effect on health-related quality of life and work productivity. Medicine (Baltimore), 2017; 96(7):e5914. doi: 10.1097/MD.0000000000005914.
Лупашко Ю., Таран Н., Березовская Е. Качество жизни у пациентов с циррозом печени до трансплантации. Materiale Conferinței “Integrare Prin Cercetare Și Inovare” Chișinău, 10-11 Noiembrie 2020. Chișinău, 2020; 2020:24-27. https://ibn.idsi.md/en/vizualizare_articol/114262 .
Комелягина Е.Ю., Анциферов М.Б., Уварова О.М. Русскоязычная версия опросника для оценки качества жизни больных с периферической полинейропатией: валидация и перспективы применения. Сахарный диабет, 2014; 17(2):56-65. ISSN 2072-0378. doi:10.14341/DM6450-4514.
Darii E., Hotineanu V., Cazacov V. Validarea şi adaptarea în limba română a chestionarului SF-LDQOL, forma scurtă, modificat prin întrebări complementare. Validation and adaptation of the combined multidimen-sional questionnaire SF-LDQOL, short form, modified through complementary questions. Arta Medica, 2016; 1(58):30-35. ISSN 1810-1879. https://core.ac.uk/download/pdf/335262449.pdf.
Mardare I., Furtunescu F. L., Claudia E. Measuring health related quality of life – methods and tools. Acta Medica Transilvanica, 2019; 24(2):6-8. E-ISSN 1453-1968, ISSN 2285-7079.
Samala N, Desai A, Vilar-Gomez E et al. Decreased Quality of Life is significantly associated with body composition in patients with Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2020; 18(13):2980-2988.e4. E-ISSN 1542-7714, ISSN 1542 - 3565. doi:10.1016/J.CGH.2020.04.046.
Li W, Kadler BK, Brindley JH, et al. The contribution of daytime sleepiness to impaired quality of life in NAFLD in an ethnically diverse population. Sci Rep. 2022; 12(1):1-9. E-ISSN 2045-2322. doi:10.1038/s41598-022-08358-y.
Younossi ZM. Non-alcoholic fatty liver disease - A global public health perspective. J Hepatol., 2019; 70(3):531-544. E-ISSN 1600-0641. doi:10.1016/J.JHEP.2018.10.033.
Younossi ZM, Stepanova M, Younossi I et al. Development and validation of a hepatitis B-specific health-related quality-of-life instrument: CLDQ-HBV. J. Viral Hepat. 2021; 28(3):484-492. E-ISSN 1365-2893. doi:10.1111/JVH.13451.
Med AC, Alay H, Yılmaz S et al. The relationship between health-related quality of life and demographic characteristics in patients with chronic hepatitis. The Anatolian Current Medical Journal, 2021; 3(2):130-135. E-ISSN 2667-565X. doi:10.38053/ACMJ.864261.
Chen P, Zhang F, Shen Y et al. Health-Related Quality of Life and Its Influencing Factors in Patients with Hepatitis B: A Cross-Sectional Assessment in Southeastern China. Can J Gastroenterol Hepatol., 2021; 2021:9937591. E-ISSN 2291-2797. doi:10.1155/2021/9937591.
Berezovscaia E., Lupasco Iu., Dumbrava V.-T. et al. Psychogastroenterology in Neurogastroenterologyopathy: A Pragmatic Clinical Approach. Proceedings of the biennial meeting of the Romanian Society of Neurogastroenterology NeurogastRO-2019, (Iasi, Romania, 07-09 November 2019). Bologna: Filodiritto Editore – Proceedings, 2020; 2020:17-23. ISBN 978-88-85813-92-2.
Romanciuc I. Calitatea vieţii pacienţilor cu hepatită cronică virală B. Sănătate Publică, Economie şi Management în Medicină, 2013; 5(50):156-160. https://repository.usmf.md/bitstream/20.500.12710/15404/1/Romanciuc_Calitatea_vietii_pacientilor_cu_hepatita_cronica_virala_B_p.156_160.pdf
Darii E. Calitatea vieţii pacienţilor operaţi pentru ciroză hepatică în raport cu metodele de tratament chirurgical aplicate. Autoreferatul tezei de doctor în ştiinţe medicale (321.13 – Chirurgie). Chișinău, 2018; 31 p. http://www.cnaa.md/files/theses/2018/53616/autoreferat_darii.pdf.
Downloads
Published
License
Copyright (c) 2026 Bulletin of the Academy of Sciences of Moldova. Medical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
